NCT01934894 2017-07-02Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial MetastasesSCRI Development Innovations, LLCPhase 2 Terminated11 enrolled 7 charts